𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Type II estrogen binding sites and antiproliferative activity of quercetin in human meningiomas

✍ Scribed by Mauro Piantelli; Alessandro Rinelli; Ettore Maorì; Nicola Maggiano; Luigi M. Larocca; Arnaldo Capelli; Massimo Scerrati; Romeo Roselli; Maurizio Iacoangeli; Giovanni Scambia; Franco O. Ranelletti

Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
561 KB
Volume
71
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Quercetin induces type-II estrogen-bindi
Quercetin induces type-II estrogen-binding sites in estrogen-receptor-negative (MDA-MB231) and estrogen-receptor-positive (MCF-7) human breast-cancer cell lines
✍ G. Scambia; S. Mancuso; P. Benedetti Panici; R. De Vincenzo; G. Ferrandina; G. B 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 French ⚖ 536 KB

## Abstract We show that flavonoids positively regulate type‐II estrogen‐binding site (type‐ll EBS) levels both in MCF‐7 (ER‐positive) and in MDA‐MB231 (ER‐negative) breast‐cancer cells. Type‐ll EBS were measured by a whole‐cell assay at 4°C for 2.5 hr using [^3^H]‐estradiol as tracer. In both cell

Growth-inhibitory effect of tamoxifen an
Growth-inhibitory effect of tamoxifen and quercetin and presence of type II estrogen binding sites in human laryngeal cancer cell lines and primary laryngeal tumors
✍ Gabriella Ferrandina; Giovanni Almadori; Nicola Maggiano; Paola Lanza; Cristiano 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 412 KB 👁 1 views

Quercetin and tamoxifen, in a range of concentrations between 0.01 and 5 M, exert a dose-dependent inhibition on the anchorage-dependent and anchorage-independent cell growth of Hep2 and CO-K3 laryngeal cancer cell lines. Cell cycle analysis revealed that the growth-inhibitory effect was associated

Type-II estrogen binding sites in a lymp
Type-II estrogen binding sites in a lymphoblastoid cell line and growth-inhibitory effect of estrogen, anti-estrogen and bioflavonoids
✍ Giovanni Scambia; Franco O. Ranelletti; Pierluigi Benedetti Panici; Mauro Piante 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 French ⚖ 566 KB

Type4 estrogen-binding sites (type-ll EBS) have been demonstrated in the human lymphoblastoid cell line IM-9 using a whole-cell assay with (6,7-'H) estradiol ('H-E,) as tracer. Competition analysis showed that the anti-estrogen tamoxifen and the flavonoids quercetin and rutin competed for (lH)-E, bi

Methyl-p-Hydroxyphenyllactate-esterase a
Methyl-p-Hydroxyphenyllactate-esterase activity and type-II estrogen-binding sites in ovarian cancer: Correlation with biological and clinico-pathological parameters
✍ Franco O. Ranelletti; Giovanni Scambia; Pierluigi Benedetti Panici; Mauro Piante 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 611 KB

We examined the levels of activity of methyl-p-hydroxyphenyllactate esterase (MeHPLA-ase) and cytosolic Type-ll-estrogenbinding sites (Type-ll EBS) in 61 and 71 cases, respectively, of primary ovarian cancer. MeHPlA-ase activity and Type-ll EBS were seen to by asymmetrically distributed, in that lev

Altered restriction pattern of the putat
Altered restriction pattern of the putative DNA binding domain of estrogen receptor or related genes in primary human meningiomas
✍ A. Vacca; V. M. Fazio; O. Gandini; P. Oppido; R. Delfini; L. Frati; A. Gulino 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 French ⚖ 389 KB

We analyzed by restriction mapping the genomic organization of the estrogen receptor gene in several primary human brain tumors in order to investigate the possible relationships between the development of these tumors and gonadal steroid hormones. In 5 out of 23 meningiomas the Eco RI restriction o